Clinical Trial Update: Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study of intravenous posaconazole (MK-5592) in Chinese participants at high risk for invasive fungal infections has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infection
• Invasive Fungal Infection

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Fungal Infection | Phase 1 | Status: COMPLETED | Results posted: 2019-12-19